Hyperfine Stock News

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine highlights data and conclusions from eleven abstracts presented at the Radiological Society of North America 2024 Annual Meeting in Chicago.

GUILFORD, Conn.--(BUSINESS WIRE)--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting.

GUILFORD, Conn.--(BUSINESS WIRE)--The new MRI standards by the IAC, effective immediately, now include portable MR scanning at the point of care.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces ten scientific abstracts highlighting ultra-low-field imaging will be presented at the RSNA 2024 Annual Meeting.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the BTIG Digital Health Forum on November 25, 2024 and the Mizuho Healthcare Conference on December 11, 2024.

Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon.

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2024 financial results and provided a business update.